JSPR Earnings Jasper Therapeutics, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–19 of 19
| Q1 2026 | 2026-03-31 | -0.04 | 2026-05-14 | 10-Q |
| FY 2025 | 2025-12-31 | -3.95 | 2026-03-30 | 10-K |
| Q3 2025 | 2025-09-30 | -4.18 | 2025-11-10 | 10-Q |
| Q2 2025 | 2025-06-30 | -3.16 | 2025-08-13 | 10-Q |
| Q1 2026 | 2025-03-31 | -1.41 | 2026-05-14 | 10-Q |
| FY 2025 | 2024-12-31 | -4.89 | 2026-03-30 | 10-K |
| Q3 2025 | 2024-09-30 | -3.25 | 2025-11-10 | 10-Q |
| Q2 2025 | 2024-06-30 | -2.00 | 2025-08-13 | 10-Q |
| Q1 2025 | 2024-03-31 | -1.03 | 2025-05-12 | 10-Q |
| FY 2024 | 2023-12-31 | -6.18 | 2025-02-28 | 10-K |
| Q3 2024 | 2023-09-30 | -4.68 | 2024-11-07 | 10-Q |
| Q2 2024 | 2023-06-30 | -3.08 | 2024-08-13 | 10-Q |
| Q1 2024 | 2023-03-31 | -1.62 | 2024-05-14 | 10-Q |
| FY 2023 | 2022-12-31 | -10.33 | 2024-03-05 | 10-K |
| Q3 2023 | 2022-09-30 | -0.67 | 2023-11-09 | 10-Q |
| Q2 2023 | 2022-06-30 | -0.35 | 2023-08-11 | 10-Q |
| Q1 2023 | 2022-03-31 | -0.06 | 2023-05-12 | 10-Q |
| FY 2022 | 2021-12-31 | -2.69 | 2023-03-08 | 10-K |
| Q3 2022 | 2021-09-30 | -7.13 | 2022-11-10 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.